FSSAI Seeks Evidence From Nestle For Lactogen Whey-Protein Claim, Nan Excella
What Happened
FSSAI has issued notices to Nestlé India over claims made on Lactogen Pro 1 Powder and Nan Excella Pro Stage 1. For Lactogen, the regulator sought scientific evidence supporting the claim that its whey protein is “easy to digest.” For Nan Excella, FSSAI flagged the claim that“5 HMOs helps support the normal immune system,” saying it was non-compliant with rules restricting claims related to physiological conditions unless specifically permitted. It also sought scientific substantiation for the product’s whey-protein claim.
Key Takeaways
Nestlé India has been asked to provide supporting evidence and explain why regulatory action should not be initiated. This is currently a notice seeking explanation, not a finding of guilt or a product ban.